Literature DB >> 9186905

Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families.

W Chen1, S Kubota, K S Kim, J Cheng, M Kuriyama, G Eggertsen, I Björkhem, Y Seyama.   

Abstract

The autosomal recessively inherited cholesterol metabolic disease, cerebrotendinous xanthomatosis (CTX), is caused by mutations in the sterol 27-hydroxylase gene. Three Japanese CTX patients from two unrelated families were studied genetically. By DNA sequence analysis a novel mutation of A for G substitution at amino acid position 372 (CGG 372Arg to CAG 372Gln) was identified in one of the CTX families. The mutation was also found in two patients from the other family, with a compound heterozygous pattern of A for G substitution at amino acid position 441 (CGG 441Arg to CAG 441Gln). The latter mutation was the same as previously reported by our group (J. Lipid Res. 1994. 35: 1031-1039). As the two mutations changed the restriction enzyme sites, rapid screening methods were developed for the detection of the carriers. Transfection of the two mutant cDNAs into COS cells resulted in markedly reduced sterol 27-hydroxylase activity. These results indicate that the two mutations are responsible for the deficiency of the sterol 27-hydroxylase activity in these patients. The features of mutations identified till now in Japanese CTX patients are also reviewed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186905

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

Review 1.  Sarcomatoid carcinoma of the bladder after simultaneous kidney-pancreas transplant: a case report and review of the literature.

Authors:  Patrick H McCrea; Michelle Chang; Gregory Bailley; Michele Molinari
Journal:  BMJ Case Rep       Date:  2012-04-28

2.  Spinal form cerebrotendinous xanthomatosis patient with long spinal cord lesion.

Authors:  Ryuta Abe; Yoshiki Sekijima; Tomomi Kinoshita; Tsuneaki Yoshinaga; Shingo Koyama; Takeo Kato; Shu-Ichi Ikeda
Journal:  J Spinal Cord Med       Date:  2016-02-25       Impact factor: 1.985

3.  Nationwide survey on cerebrotendinous xanthomatosis in Japan.

Authors:  Yoshiki Sekijima; Shingo Koyama; Tsuneaki Yoshinaga; Masayoshi Koinuma; Yuji Inaba
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

4.  Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27).

Authors:  S Sugama; A Kimura; W Chen; S Kubota; Y Seyama; N Taira; Y Eto
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

5.  Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism.

Authors:  N Wakamatsu; M Hayashi; H Kawai; H Kondo; Y Gotoda; Y Nishida; R Kondo; S Tsuji; T Matsumoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

6.  Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees.

Authors:  M H Lee; S Hazard; J D Carpten; S Yi; J Cohen; G T Gerhardt; G Salen; S B Patel
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

7.  Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.

Authors:  Jiannan Chen; Zhe Zhao; Hongrui Shen; Qi Bing; Nan Li; Xuan Guo; Jing Hu
Journal:  BMC Neurol       Date:  2022-05-16       Impact factor: 2.903

8.  A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis.

Authors:  Hauke Schneider; Alexandra Lingesleben; Hans-Peter Vogel; Rita Garuti; Sebastiano Calandra
Journal:  Orphanet J Rare Dis       Date:  2010-10-06       Impact factor: 4.123

9.  A Late-onset and Relatively Rapidly Progressive Case of Pure Spinal Form Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.

Authors:  Ken Takasone; Teruya Morizumi; Katsuya Nakamura; Yusuke Mochizuki; Tsuneaki Yoshinaga; Shingo Koyama; Yoshiki Sekijima
Journal:  Intern Med       Date:  2020-06-23       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.